Liftstream is an executive search recruitment company in the life sciences sector
Swedish Pharmalink receives Orphan Drug Approval for Busulipo
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Busulipo, cancer, clinical studies, clinical trials, EMA, FDA, funding, gold standard, hematopoietic stem cell transplantation, HSCT, Investinor, Johan Häggblad, Karolinska Institute, Medicon Valley, Nefecon, oncology, Orphan Drug, pharmacokinetics, Pharmalink Ab, primary IgA nephropathy, series C, sweden, venture capital
Leave a comment